Vitamin B6 in clinical neurology - PubMed (original) (raw)
Review
Vitamin B6 in clinical neurology
A L Bernstein. Ann N Y Acad Sci. 1990.
Abstract
Many conditions in clinical neurology may be responsive to pyridoxine as a therapeutic agent. The current difficulty is in trying to isolate the conditions that are most likely to respond. Treating seizures is a major part of a neurologic practice. Our current therapeutic agents are only partially successful and limited by multiple side effects. One problem is that patients often have to take these agents for an entire lifetime, further raising the risk of toxicity. If pyridoxine supplementation can improve the efficacy of currently used medications, it will be gladly accepted into our therapeutic arsenal. Headache, chronic pain, and depression all appear to run together in many of our patients. The observations that serotonin deficiency is a common thread between them and that pyridoxine can raise serotonin levels open a wide range of therapeutic options. Small studies have been carried out with mixed success. Comparison with amitriptyline in the treatment of headache appears to show about equal efficacy, although side effects would be expected to be more of a problem with the amitriptyline. Behavioral disorders are relatively common and continue to be a major problem, disrupting the lives of the patients and their families. Current treatments are not acceptable to most people because of the risk of side effects with long-term usage. If, as Dr. Feingold suggests, many of these problems are caused by "toxic" exposures to chemicals that are pyridoxine antagonists, supplementation at early ages may reduce the incidence of hyperactivity and aggressive behavior. This raises the question of safety. Is pyridoxine safe for long-term use in large segments of the population, including children? The studies on children with Down's syndrome and autism, utilizing much higher doses than are used for other therapeutic purposes, seem to indicate relative safety if carefully monitored. Studies involving large population groups with carpal tunnel syndrome, all adults, using 100-150 mg/day have shown minimal or no toxicity in five- to 10-year studies. Women self-medicating for PMS taking 500 to 5000 mg/day have shown peripheral neuropathy within one to three years. It would appear from this retrospective analysis that pyridoxine is safe at doses of 100 mg/day or less in adults. In children there is not enough data to make any sort of suggestion. Because the major neurologic complication is a peripheral neuropathy and the causes of this condition are myriad, pyridoxine may cause neuropathy only in patients with a pre-existing susceptibility to this condition.
Similar articles
- Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review.
Aufiero E, Stitik TP, Foye PM, Chen B. Aufiero E, et al. Nutr Rev. 2004 Mar;62(3):96-104. doi: 10.1111/j.1753-4887.2004.tb00030.x. Nutr Rev. 2004. PMID: 15098856 Review. - Brief communication: effect of pharmacologic doses of vitamin B6 on carpal tunnel syndrome, electroencephalographic results, and pain.
Bernstein AL, Dinesen JS. Bernstein AL, et al. J Am Coll Nutr. 1993 Feb;12(1):73-6. doi: 10.1080/07315724.1993.10718286. J Am Coll Nutr. 1993. PMID: 8440821 - Carpal tunnel syndrome and vitamin B6.
Laso Guzmán FJ, González-Buitrago JM, de Arriba F, Mateos F, Moyano JC, López-Alburquerque T. Laso Guzmán FJ, et al. Klin Wochenschr. 1989 Jan 4;67(1):38-41. doi: 10.1007/BF01736533. Klin Wochenschr. 1989. PMID: 2921840 - Motor and sensory neuropathy secondary to excessive pyridoxine ingestion.
Foca FJ. Foca FJ. Arch Phys Med Rehabil. 1985 Sep;66(9):634-6. Arch Phys Med Rehabil. 1985. PMID: 2994596 - Carpal tunnel syndrome: current theory, treatment, and the use of B6.
Holm G, Moody LE. Holm G, et al. J Am Acad Nurse Pract. 2003 Jan;15(1):18-22. doi: 10.1111/j.1745-7599.2003.tb00250.x. J Am Acad Nurse Pract. 2003. PMID: 12613409 Review.
Cited by
- Association of Pyridoxal 5'-Phosphate with Sleep-Related Problems in a General Population.
Ge L, Luo J, Zhang L, Kang X, Zhang D. Ge L, et al. Nutrients. 2022 Aug 26;14(17):3516. doi: 10.3390/nu14173516. Nutrients. 2022. PMID: 36079774 Free PMC article. - Low Serum Pyridoxine Levels Worsen Seizure Control in Adult Epilepsy Patients.
Rane S, Elrahi S, Villarreal J, Zulfi H, Fang X, Graf D, Rodriguez R, Garza A, Thottempudi N, Rai P, Masel T. Rane S, et al. Cureus. 2022 Jun 5;14(6):e25669. doi: 10.7759/cureus.25669. eCollection 2022 Jun. Cureus. 2022. PMID: 35812624 Free PMC article. - Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment.
Córdova-Martínez A, Caballero-García A, Pérez-Valdecantos D, Roche E, Noriega-González DC. Córdova-Martínez A, et al. Biomedicines. 2022 May 2;10(5):1051. doi: 10.3390/biomedicines10051051. Biomedicines. 2022. PMID: 35625788 Free PMC article. Review. - B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.
Calderón-Ospina CA, Nava-Mesa MO. Calderón-Ospina CA, et al. CNS Neurosci Ther. 2020 Jan;26(1):5-13. doi: 10.1111/cns.13207. Epub 2019 Sep 6. CNS Neurosci Ther. 2020. PMID: 31490017 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical